Article PDF
References
Dyck PJ, Prineas J . Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PI, Thomas PK, Griffin JW, et al. editors. Peripheral neuropathy. 3rd ed. Philadelphia: Saunders, 1993:1498–517.
Oh KT, Boldt HC, Dansi RP . Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration. Am J Ophthalmol 1997;124:416–8
McGrath MA, Wechsler F, Hunyor ABL, Penny R . Systemic factors contributing to retinal vein occlusion. Arch Intern Med 1978;138:216–20
Schussler O, Lantoine F, Devynck MA, Glotz D, David- Dufilho M . Human immunoglobulins inhibit thrombin- induced Ca2+ movements and nitric oxide production in endothelial cells. J BioI Chern 1996;271:26473–6
Bagdasarian A, Tonetta S, Harel W, Mamidi R, Uemura Y . IVIG adverse reactions: potential role of cytokines and vasoactive substances. Vox Sang 1998;74:74–82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harkness, K., Goulding, P. Central retinal vein occlusion complicating treatment with intravenous immunoglobulin. Eye 14, 662–663 (2000). https://doi.org/10.1038/eye.2000.163
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.163
This article is cited by
-
Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature
Annals of Hematology (2005)
-
Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature
Annals of Hematology (2004)